1. Market Engineering Research
Analysis of The Pharmaceutical Industry in Ethiopia
Identifying and Evaluating Market Trends for Specific Therapeutic
Agents
Healthcare (HC)
Research Service Code: M863-52
Completion date: August 2012

2. Contents
Section Slide Numbers
 Summary of Study 3
 Research Aims and Objectives 4
 Scope of Research 5
 Research and Respondent Scope 6
 Methodology Followed 7
 Research Deliverables 8
 Benefits of Research 10
 Frost and Sullivan Company Information and Contacts 11
M863-52
Contents 2

3. Summary of Study
This research service provides a strategic analysis of the
Ethiopian Pharmaceutical Industry over the period 2009 to
2017. The market size and growth of the total pharmaceutical
industry, including six main therapeutic segments that
characterize the prescription drug market are presented. A
brief competitive overview is provided for the total market.
Ethiopia
Insight into the market dynamics, particularly the drivers and Market Value (2011)
restraints as well as the opportunities of the pharmaceutical ` $422.2 M
market, is provided.
• A key finding of this research identifies the Pharmaceutical industry in
Ethiopia to be worth $945.8 million in 2017.
• In addition to the large pharmaceutical market opportunity, the industry is
expected to witness a CAGR of 14.8 per cent over the forecast period
(2012-2017).
Ethiopian
• The Anti-infectives, Cardiovascular and Diabetes Therapeutic segments Pharmaceutical
present the largest opportunity for growth.
• Generic pharmaceutical products dominate the market as they favour Industry
highly price sensitive consumers.
M863-52 3

4. Research Aims and Objectives—Key Questions
This Study Will Answer
The aim of this research service is to characterise the opportunities that exists for specific therapeutic
classes within the Ethiopian Pharmaceutical Industry
How is the health care in Ethiopia structured? What regulations govern the pharmaceutical industry
1
and how will these regulations impact the market in the future?
What is the size and growth potential of the pharmaceutical industry in Ethiopia? What are the drivers,
2
restraints, and challenges within the industry?
What is the size and growth potential of various therapeutic segments in the pharmaceutical industry?
3
What opportunities exists for each of these segments?
Who are the existing competitors in the Ethiopian pharmaceutical industry and how is their marketing
4
strategy structured to meet basic customer needs?
Who are the various competitors of the various therapeutic segments in the industry? How is the
5
market divided amongst these competitors?
What factors contribute to the key growth opportunities in each therapeutic segment and what
6
strategic recommendations can assist participants to capitalize on those opportunities?
M863-52 4

5. Scope of Research
Geographic Scope
This research service focuses on the Ethiopian Pharmaceutical market.
Product Scope
The research service will focus on specific pharmaceutical therapeutic Ethiopia
segments namely; Anti-infectives, Cardiovascular, Diabetes, Central
nervous System, Respiratory and Oncology
`
Total Pharmaceutical Industry
Generic Branded
products products
Anti-Infectives Cardiovascular Diabetes Respiratory Central Nervous Oncology
Segment Segment Segment Segment System Segment Segment
M863-52 5

6. Methodology & Respondent Scope
For Market Engineering research, Frost & Sullivan utilises tried and tested
marketing techniques to provide structure to the research and an easy format
to compare results across different countries, markets and over time.
This project was carried out using primary research (telephone or face-to-face
interviews) and secondary (published and online material) as the principle
methods of data gathering. The focus of the interviews for this project were
primarily the respondent types outlined in the figure below.
Organisation Type Target Designations Type of Information
Public and Private Hospitals and Expenditure, Key Products in Demand,
Procurement Officers, Directors of
Clinics Key Products in Use, Challenges,
Pharmacy
Procurement Process, Key Suppliers
Regulatory Process, Industry Overview,
Regulatory bodies, Associations Administration Officers, Directors Industry Structure, Key Participants,
and Societies Expenditure, Government Projects
Industry Trends, Technology Trends,
Pharmaceutical Manufacturers, CEOs, MDs, Marketing Managers, Challenges, Drivers, Restraints, Revenues,
Suppliers & Distributors General Managers, Sales Managers Growth Opportunities, Competitive
Dynamics
M863-52 6

7. Methodology Followed
This Research Service provides a strategic overview
of the Ethiopian Pharmaceutical Industry and follows
the principle of Frost & Sullivan's Market Engineering
research methodology. This measurement-based
methodology focuses on market measurement,
analysis, forecasting, strategy development and
monitoring.
Data retrieved from the secondary and primary
research regarding the Ethiopian Pharmaceutical
Industry was compiled, tested and engineered to
provide a market structure and market forecasts Frost & Sullivan’s
Market Engineering Research Methodology
This study is based on thorough secondary and primary research principles. Extensive
interviews were conducted with key stakeholders. Market participants in the supply side of
pharmaceutical products also provided key market information allowing for a top-down
analysis of this market in Ethiopia.
M863-52 7

8. Research Deliverables 1/2
Market
Market
Engineering
Overview
Measurements
Market Drivers Competitive
and Restraints Assessment
M863-52 8

9. Research Deliverables 2/2
Forecast and Pharmaceutical
Trends Procurement
Regulatory Healthcare
Overview Overview
M863-52 9

10. Benefits of Research
Provides insights into industry
dynamics
Analysis of the key Analysis of the Pharmaceutical
market players within 1 Industry in
each country Ethiopia
8 2
Comprehensive revenue
7
Research 3 Identifies growth opportunities
forecasts by total
Market and Therapeutic Benefits within the Market and
Segments Therapeutic Segments
6 4
5
Key market drivers and Provides a competitive analysis
restraints for the and recommendations
Pharmaceutical Industry
Overview of regulatory
systems and supply of
pharmaceutical product in
the country
M863-52 10

11. Frost & Sullivan Contacts
Phil Howarth
Danielle Kruger
Operations Director
Account Manager
Frost & Sullivan Africa
Frost & Sullivan
+27 21 680 3269
+27 21 680 3262
phil.howarth@frost.com
+27 72 878 0698
danielle.kruger@frost.com
Kate Howarth Mani James
Sales Manager Programme Manager
Frost & Sullivan Africa Chemicals, Materials and Food
+27 21 680 3261 +27 21 680 3208
kate.howarth@frost.com mani.james@frost.com
M863-52 11